Lung Neoplasms
Showing 1 - 25 of 277
Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)
Recruiting
- Protein Kinase Inhibitors
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Nov 9, 2023
MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
Not yet recruiting
- Lung Neoplasms
- +2 more
- Tumor samples
-
Bordeaux, FranceCHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
Aug 28, 2023
Lung Cancer, Multiple Pulmonary Nodules, Lung Tumors Trial in Orlando, Rochester, Pinehurst (Ion Endoluminal System)
Not yet recruiting
- Lung Cancer
- +8 more
- Ion Endoluminal System
-
Orlando, Florida
- +2 more
Aug 16, 2023
Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules
Recruiting
- Neoplasms
- +13 more
- HTL0039732 Capsules
- HTL0039732 Capsules and atezolizumab infusion
-
Cambridge, United Kingdom
- +4 more
Jul 5, 2023
Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined
Not yet recruiting
- Lung Neoplasms
- Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
- Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
- (no location specified)
Jun 12, 2023
Lung Tumors Trial (Active Cycle of Breathing Techniques)
Not yet recruiting
- Lung Neoplasms
- Active Cycle of Breathing Techniques
- (no location specified)
May 25, 2023
Delirium, Aged, Lung Tumors Trial (Acetaminophen and Ibuprofen, Normal saline)
Not yet recruiting
- Delirium
- +4 more
- Acetaminophen and Ibuprofen
- Normal saline
- (no location specified)
Apr 17, 2023
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)
Recruiting
- Non-Small Cell Lung Cancer
- +14 more
-
Glendale, California
- +12 more
Feb 2, 2023
Lung Tumors, PET-CT Specimen Imager Trial in Ghent (AURA10 Specimen Imager)
Not yet recruiting
- Lung Neoplasms
- PET-CT Specimen Imager
- AURA10 Specimen Imager
-
Ghent, BelgiumUniversity Hospital Ghent
Jan 11, 2023
Lung Tumors, Pneumothorax Trial (HFNO)
Not yet recruiting
- Lung Neoplasms
- Pneumothorax
- HFNO
- (no location specified)
Dec 23, 2022
Lung Tumors Trial in Altoona, Philadelphia (nCLE aided RANB biospy)
Recruiting
- Lung Neoplasms
- nCLE aided RANB biospy
-
Altoona, Pennsylvania
- +1 more
Dec 27, 2022
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)
Recruiting
- Non-Small Cell Lung Cancer
- +13 more
- furmonertinib 240 mg
- +2 more
-
Yuma, Arizona
- +37 more
Dec 14, 2022
Specimen Banking From Patients With Lung Cancer
Recruiting
- Lung Neoplasms
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Dec 13, 2022
Hydroxychloroquine, Gemcitabine, Lung Tumors Trial (Hydroxychloroquine Combined With Gemcitabine)
Not yet recruiting
- Hydroxychloroquine
- +2 more
- Hydroxychloroquine Combined With Gemcitabine
- (no location specified)
Dec 3, 2022
Oncogenes and Resistance Mechanisms in Lung Cancer
Recruiting
- Lung Neoplasms
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Oct 31, 2022
Tumors, Lung Tumors Trial in St Leonards (MLC Tracking)
Active, not recruiting
- Neoplasms
- Lung Neoplasms
- MLC Tracking
-
St Leonards, New South Wales, AustraliaRoyal North Shore Hospital
Oct 25, 2022
NSCLC, Lung Diseases, Lung Tumors Trial in New Haven (Sitravatinib, Pembrolizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +8 more
-
New Haven, ConnecticutYale University
Oct 26, 2022
Related to Chronic Cough After Pulmonary Resection
Recruiting
- Persistent Cough
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Oct 16, 2022
Lung Adenocarcinoma, Lung Tumors Trial run by the NCI (osimertinib, LAT)
Completed
- Lung Adenocarcinoma
- Lung Neoplasms
- osimertinib
- LAT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 17, 2022
Solitary Pulmonary Nodule, Coin Lesion, Pulmonary, Lung Tumors Trial in Pasadena (More Frequent Surveillance Strategy, Less
Active, not recruiting
- Solitary Pulmonary Nodule
- +3 more
- More Frequent Surveillance Strategy
- Less Frequent Surveillance Strategy
-
Pasadena, CaliforniaKaiser Permanente Southern California
Sep 30, 2022
Progression of Invasive Squamous Cell Carcinoma
Recruiting
- Carcinoma, Squamous Cell
- +10 more
- DNA Extraction
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 27, 2022
Circulating Tumor Cells (CTC) in Lung Cancer
Recruiting
- Lung Neoplasms
- Blood draw
-
Indianapolis, Indiana
- +1 more
Sep 23, 2022